FRANKLYN G PRENDERGAST Insider Trading
Get free email notifications about insider trading for FRANKLYN G PRENDERGAST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANKLYN G PRENDERGAST. FRANKLYN G PRENDERGAST is a Director in LILLY ELI & CO ($LLY) and a Director in NeuBase Therapeutics, Inc. ($OHRP) and a Director in CANCER GENETICS, INC ($CGIX) and a Director in Lantern Pharma Inc. ($LTRN).
Address: LILLY CORPORATE CENTER INDIANAPOLIS 46285 IN
Companies in which FRANKLYN G PRENDERGAST is an Insider
ELI LILLY & Co
Trading Symbol: LLYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 68,574 shares
Current Value: $5,328,200
Latest Transaction: Nov 22 2017
$LLY Market Capitalization: $83.74B
$LLY Previous Close: $77.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lantern Pharma Inc.
Trading Symbol: LTRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeuBase Therapeutics, Inc.
Trading Symbol: NBSEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 11 2020
$NBSE Market Capitalization: $48.55M
$NBSE Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vyant Bio, Inc.
Trading Symbol: CGIXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 12,500 shares
Current Value: $30,000
Latest Transaction: Aug 21 2019
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of FRANKLYN G PRENDERGAST
Sentiment: All, LLY, LTRN, NBSE, CGIX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 11 2020 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 8.80 | 14,634 | 128,779 | 14,634 | |
Jun 15 2020 | LTRN | Lantern Pharma Inc ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 15.00 | 9,135 | 137,025 | 9,135 | |
Aug 21 2019 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Jul 16 2019 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
Jul 16 2019 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
Nov 22 2017 | LLY | LILLY ELI & CO | PRENDERGAST FRANKLYN G | Director | Grant | A | 83.18 | 802 | 66,710 | 68,574 | 67.8 K to 68.6 K (+1.18 %) |
Oct 02 2017 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 2.75 | 5,000 | 13,750 | 5,000 |